Zhang J - Search Results

1

Synthesis and biological evaluation of novel oxazolo[5,4-d]pyrimidines as potent VEGFR-2 inhibitors.

Deng YH, Xu D, Su YX, Cheng YJ, Yang YL, Wang XY, Zhang J, You QD, Sun LP. Deng YH, et al. Among authors: zhang j. Chem Biodivers. 2015 Apr;12(4):528-37. doi: 10.1002/cbdv.201400270. Chem Biodivers. 2015. PMID: 25879498

2

Phage-derived fully human antibody scFv fragment directed against human vascular endothelial growth factor receptor 2 blocked its interaction with VEGF.

Zhang J, Li H, Wang X, Qi H, Miao X, Zhang T, Chen G, Wang M. Zhang J, et al. Among authors: zhang t. Biotechnol Prog. 2012 Jul;28(4):981-9. doi: 10.1002/btpr.1559. Epub 2012 Jun 18. Biotechnol Prog. 2012. PMID: 22581629

3

The antiangiogenic activity of a soluble fragment of the VEGFR extracellular domain.

Li H, Cao W, Chen Z, Acheampong DO, Jin H, Li D, Zhang J, Wang M. Li H, et al. Among authors: zhang j. Biomed Pharmacother. 2013 Sep;67(7):599-606. doi: 10.1016/j.biopha.2013.06.001. Epub 2013 Jul 10. Biomed Pharmacother. 2013. PMID: 23906761

4

Generation and characterization of a human nanobody against VEGFR-2.

Ma L, Gu K, Zhang CH, Chen XT, Jiang Y, Melcher K, Zhang J, Wang M, Xu HE. Ma L, et al. Among authors: zhang ch, zhang j. Acta Pharmacol Sin. 2016 Jun;37(6):857-64. doi: 10.1038/aps.2016.2. Epub 2016 Apr 25. Acta Pharmacol Sin. 2016. PMID: 27108602 Free PMC article.

5

[Expression and function identification of extracellular domain 3 of human vascular endothelial growth factor receptor KDR].

Zhang J, Zhang Y, Li H, Chen W, Zhang T, Wang M. Zhang J, et al. Among authors: zhang t, zhang y. Sheng Wu Gong Cheng Xue Bao. 2008 Nov;24(11):1962-7. Sheng Wu Gong Cheng Xue Bao. 2008. PMID: 19256346 Chinese.

6

Preparation of extracellular domain 3 of human VEGF receptor-2 and the monitoring of its real-time binding to VEGF by biosensors.

Zhang J, Li H, Chen W, Cao P, Wang M. Zhang J, et al. Biotechnol Prog. 2009 Nov-Dec;25(6):1703-8. doi: 10.1002/btpr.252. Biotechnol Prog. 2009. PMID: 19731341

7

[Construction and expression of an anti-EGFR/anti-KDR bispecific single-chain diabody].

Zhou YQ, Zhang J, Jin HZ, He Y, Wang T, Wang M. Zhou YQ, et al. Among authors: zhang j. Yao Xue Xue Bao. 2012 Oct;47(10):1317-22. Yao Xue Xue Bao. 2012. PMID: 23289143 Chinese.

8

Periplasmic expression optimization of VEGFR2 D3 adopting response surface methodology: antiangiogenic activity study.

Cao W, Li H, Zhang J, Li D, Acheampong DO, Chen Z, Wang M. Cao W, et al. Among authors: zhang j. Protein Expr Purif. 2013 Aug;90(2):55-66. doi: 10.1016/j.pep.2013.04.010. Epub 2013 May 13. Protein Expr Purif. 2013. PMID: 23680780

9

[Construction of anti-VEGFR-2 IgG1 like human antibody and its expression in CHO-k cells].

Li ZK, He Y, Zhang J, Xie W, Cao WL, Wang ZG, Wang M. Li ZK, et al. Among authors: zhang j. Yao Xue Xue Bao. 2013 Oct;48(10):1544-9. Yao Xue Xue Bao. 2013. PMID: 24417080 Chinese.

10

Generation and characterization of a novel human IgG1 antibody against vascular endothelial growth factor receptor 2.

Xie W, Li D, Zhang J, Li Z, Acheampong DO, He Y, Wang Y, Chen Z, Wang M. Xie W, et al. Among authors: zhang j. Cancer Immunol Immunother. 2014 Sep;63(9):877-88. doi: 10.1007/s00262-014-1560-9. Epub 2014 Jun 4. Cancer Immunol Immunother. 2014. PMID: 24893856 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180,063 results

Search Page

Filters